Literature DB >> 18651562

Treatment of pediatric brain tumors.

Matthias Karajannis1, Jeffrey C Allen, Elizabeth W Newcomb.   

Abstract

Over the past decades considerable advances have been made in neurosurgery, radiotherapy and chemotherapy resulting in improved survival and cure rates for children with brain tumors. Here we review four of the most common subtypes of pediatric brain tumors, low-grade and high-grade astrocytomas, medulloblastomas and ependymomas, highlighting their molecular features regarding their tumor biology, and promising potential therapeutic targets that may hold promise for finding new "molecular targeted" drugs. Importantly, appropriate clinical trial design will play a critical role in the evaluation of new and novel treatment approaches for pediatric brain tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18651562      PMCID: PMC2574972          DOI: 10.1002/jcp.21544

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  76 in total

1.  Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

Authors:  Piergiorgio Modena; Elena Lualdi; Federica Facchinetti; Joris Veltman; James F Reid; Simone Minardi; Irene Janssen; Felice Giangaspero; Marco Forni; Gaetano Finocchiaro; Lorenzo Genitori; Flavio Giordano; Riccardo Riccardi; Eric F P M Schoenmakers; Maura Massimino; Gabriella Sozzi
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

Review 2.  Methodology of clinical trials with new molecular-targeted agents: where do we stand?

Authors:  A Morabito; M Di Maio; E De Maio; N Normanno; F Perrone
Journal:  Ann Oncol       Date:  2006-06       Impact factor: 32.976

3.  Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.

Authors:  Stergios Zacharoulis; Adam Levy; Susan N Chi; Sharon Gardner; Marc Rosenblum; Douglas C Miller; Ira Dunkel; Blanca Diez; Richard Sposto; Lingyun Ji; Shahab Asgharzadeh; Juliette Hukin; Jean Belasco; Ronald Dubowy; Stewart Kellie; Amanda Termuhlen; Jonathan Finlay
Journal:  Pediatr Blood Cancer       Date:  2007-07       Impact factor: 3.167

Review 4.  In search of the medulloblast: neural stem cells and embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Neurosurg Clin N Am       Date:  2007-01       Impact factor: 2.509

5.  Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.

Authors:  Margaret C Thompson; Christine Fuller; Twala L Hogg; James Dalton; David Finkelstein; Ching C Lau; Murali Chintagumpala; Adekunle Adesina; David M Ashley; Stewart J Kellie; Michael D Taylor; Tom Curran; Amar Gajjar; Richard J Gilbertson
Journal:  J Clin Oncol       Date:  2006-03-27       Impact factor: 44.544

Review 6.  Brainstem tumors: where are we today?

Authors:  Pablo F Recinos; Daniel M Sciubba; George I Jallo
Journal:  Pediatr Neurosurg       Date:  2007       Impact factor: 1.162

7.  Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

Authors:  C Colin; N Baeza; C Bartoli; F Fina; N Eudes; I Nanni; P-M Martin; L Ouafik; D Figarella-Branger
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

8.  Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.

Authors:  Ken C Lo; Michael R Rossi; Charles G Eberhart; John K Cowell
Journal:  Brain Pathol       Date:  2007-04-23       Impact factor: 6.508

9.  Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age.

Authors:  David T W Jones; Koichi Ichimura; Lu Liu; Danita M Pearson; Karen Plant; V Peter Collins
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

10.  Imaging response assessment in oncology.

Authors:  S D Curran; A U Muellner; L H Schwartz
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

View more
  28 in total

1.  Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.

Authors:  Amy K Keating; Grace K Kim; Ashley E Jones; Andrew M Donson; Kathryn Ware; Jean M Mulcahy; Dana B Salzberg; Nicholas K Foreman; Xiayuan Liang; Andrew Thorburn; Douglas K Graham
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

Review 2.  Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.

Authors:  Jon D Larson; David A Largaespada
Journal:  In Vivo       Date:  2012 Jul-Aug       Impact factor: 2.155

Review 3.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

4.  Harvey Cushing's early experience with pediatric gliomas.

Authors:  Neda I Sedora-Román; Courtney Pendleton; Ahmed Mohyeldin; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2011-02-02       Impact factor: 1.475

5.  "Groans less, seems more comfortable:" Harvey Cushing's redefinition of success in the operative treatment of pediatric intracranial lesions.

Authors:  Courtney Pendleton; George I Jallo; Aaron A Cohen-Gadol; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2010-10-27       Impact factor: 1.475

6.  Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.

Authors:  Jessica K Roberts; Anna V Birg; Tong Lin; Vinay M Daryani; John C Panetta; Alberto Broniscer; Giles W Robinson; Amar J Gajjar; Clinton F Stewart
Journal:  Drug Metab Dispos       Date:  2016-04-06       Impact factor: 3.922

7.  Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.

Authors:  Matthew D Stephen; Peter E Zage; Steven G Waguespack
Journal:  Int J Pediatr Endocrinol       Date:  2011-03-06

8.  Super-selective basilar artery infusion of bevacizumab and cetuximab for multiply recurrent pediatric ependymoma.

Authors:  P Rajappa; J Krass; H A Riina; J A Boockvar; Jeffrey P Greenfield
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

Review 9.  Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.

Authors:  Sydney T Grob; Jean M Mulcahy Levy
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

Review 10.  New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.

Authors:  Nina F Schor
Journal:  Pharmacol Ther       Date:  2009-01-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.